secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2026-05-21T12:00:44+00:00
Accession:  0001193125-26-233429
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix cuts FY2026 guidance as CMS cuts bone stimulator reimbursement ~10%
----------------------------------------------------------------------------

- CMS reduced Medicare reimbursement for HCPCS codes E0747, E0748, E0760 by ~10% effective May 18, 2026.
- FY2026 net sales guidance lowered to $838M-$848M; non-GAAP adjusted EBITDA to $90M-$93M.
- Company no longer expects positive free cash flow in FY2026; three-year financial targets abandoned.
- Further CMS changes could require additional outlook revisions; long-term impact still being evaluated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312526233429/0001193125-26-233429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312526233429/ofix-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-233429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer